Rationale and usability findings of an e-health intervention to improve oral anticancer adherence among breast cancer survivors: The My Journey mindfulness study

BACKGROUND: Approximately 80% of breast cancer survivors are prescribed oral endocrine therapy (ET) medication for 5–10 years following primary treatment, making adherence to ET a critical aspect of cancer survivorship care. Despite the benefits of ET, non-adherence is problematic, and up to half of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanez, Betina, Oswald, Laura B., Van Denburg, Alyssa N., Baik, Sharon H., Czech, Katherine A., Buitrago, Diana, Maletich, Carly, Wortman, Katy, Penedo, Frank J., Victorson, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889091/
https://www.ncbi.nlm.nih.gov/pubmed/35252622
http://dx.doi.org/10.1016/j.conctc.2022.100898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889091/
https://www.ncbi.nlm.nih.gov/pubmed/35252622
http://dx.doi.org/10.1016/j.conctc.2022.100898

Ejemplares similares